{"id":"W2146473694","doi":"10.1200/jco.2004.08.080","title":"Quality of Life in Ovarian Cancer Patients: Comparison of Paclitaxel Plus Cisplatin, With Cyclophosphamide Plus Cisplatin in a Randomized Study","year":2004,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; Queen's University; University Health Network","funders":"","keywords":"Cisplatin; Medicine; Paclitaxel; Oncology; Cyclophosphamide; Internal medicine; Randomized controlled trial; Ovarian cancer; Chemotherapy; Cancer; Gynecology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003878472,0.0008827506,0.002755464,0.0006977588,0.0004910631,0.001196518,0.0008215569,0.001823993,0.004913988],"category_scores_gemma":[0.006719443,0.0006466879,0.00316415,0.0008717552,0.001201918,0.0007649838,0.0006240653,0.001927422,0.0003956557],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001259664,"about_ca_system_score_gemma":0.001834793,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009504742,"about_ca_topic_score_gemma":0.001442658,"domain_scores_codex":[0.9961357,0.002721829,0.0003204681,0.0003296564,0.0002904561,0.000201899],"domain_scores_gemma":[0.9955696,0.001899507,0.0012598,0.0002598373,0.0002194368,0.000791818],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9750723,0.005160636,0.001732366,0.0006728395,0.001242342,0.00001922284,0.00003429177,0.0002230335,0.0004109245,0.00005565328,0.0001977533,0.01517868],"study_design_scores_gemma":[0.937225,0.05868271,0.002694437,0.00004892781,0.0006644528,0.00001615379,0.00001567247,0.0002027479,0.0001123502,0.00005967684,0.0002704955,0.000007383234],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9803137,0.009920645,0.0006304803,0.0008527039,0.0004909423,0.00595201,0.0005919122,0.00005346774,0.001194184],"genre_scores_gemma":[0.986797,0.003378864,0.001106632,0.0006363509,0.0005045218,0.006509242,0.0005587408,0.000008772112,0.0004999858],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004913988,"threshold_uncertainty_score":0.02051157,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1460726142932529,"score_gpt":0.5286768606947838,"score_spread":0.3826042464015309,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}